Literature DB >> 837325

Preliminary report of the lung cancer detection program in New York.

M Melamed, B Flehinger, D Miller, R Osborne, M Zaman, C McGinnis, N Martini.   

Abstract

The early lung cancer detection program in New York is described, and preliminary prevalence rate data are reported. Cigarette-smoking men over the age of 45, who are considered at high risk, are encouraged to enroll in the program and, to date, 6,612 have done so. These men receive PA and lateral chest x-rays annually, while a randomly selected sub-population of about half also have sputum cytology every four months. A controlled study of sputum cytology as an adjunct to the chest x-ray is now in progress. There were 15 cases of late lung cancer (pathologic stages II and III) detected at the initial examination, and 11 early cases (pathologic stages O and I). In the population of 3,387 men who had x-rays alone there were three early lung cancers detected; in the population of 3,225 men who had both examinations four early cancers were detected by x-ray and four by cytology. In addition, three cases of larynx cancer were detected by cytology. The early lung cancers detected by x-ray were peripheral and most were bronchiolar or adenocarcinoma; the early cancers detected by cytology were central epidermoid carcinoma of major bronchi. No early carcinomas were detected by both techniques. These findings suggest that a combination of chest x-rays and sputum cytology can be more effective than either one alone in detecting early lung cancer.

Entities:  

Mesh:

Year:  1977        PMID: 837325     DOI: 10.1002/1097-0142(197702)39:2<369::aid-cncr2820390202>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  The periodic health examination. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  Can Med Assoc J       Date:  1979-11-03       Impact factor: 8.262

2.  Cancer screening in older adults.

Authors:  J M Walsh
Journal:  West J Med       Date:  1992-05

3.  [Not Available].

Authors:  R Hebert; J Y Dubois; C Fish; L Frenette; O Doiron; R Bernier
Journal:  Can Fam Physician       Date:  1981-03       Impact factor: 3.275

4.  Resectability of lung cancer and survival in the New York Lung Cancer Detection Program.

Authors:  H J Flehinger; M R Melamed; M B Zaman; R T Heelan; W Perchick; N Martini
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

Review 5.  Screening for lung cancer.

Authors:  Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal:  Cochrane Database Syst Rev       Date:  2013-06-21

6.  Screening for occult lung cancer.

Authors:  T H Barclay; J H MacIntosh
Journal:  Can Med Assoc J       Date:  1983-04-15       Impact factor: 8.262

7.  Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.

Authors:  V Paul Doria-Rose; Pamela M Marcus; Eva Szabo; Melvyn S Tockman; Myron R Melamed; Philip C Prorok
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

8.  Automated Pulmonary Nodule Classification in Computed Tomography Images Using a Deep Convolutional Neural Network Trained by Generative Adversarial Networks.

Authors:  Yuya Onishi; Atsushi Teramoto; Masakazu Tsujimoto; Tetsuya Tsukamoto; Kuniaki Saito; Hiroshi Toyama; Kazuyoshi Imaizumi; Hiroshi Fujita
Journal:  Biomed Res Int       Date:  2019-01-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.